Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.
Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial. Inflamm Bowel Dis. 2012 May; 18(5):818-25.